Skip to main navigation
Skip to search
Skip to main content
University of Southern Denmark Home
Help & FAQ
Dansk
English
Home
Researchers
Research Units
Research output
Activities
Projects
Press / Media
Prizes
Teaching
Impacts
Datasets
Search by expertise, name or affiliation
Åsa Fex Svenningsen offentligt CV
Åsa Fex Svenningsen offentligt CV
View Scopus Profile
Åsa Fex Svenningsen
PhD
Department of Molecular Medicine
Associate Professor
,
Neurobiology Research Unit
https://orcid.org/0000-0002-5651-265X
Phone
+4565503812
Email
aasvenningsen
health.sdu
dk
Overview
Fingerprint
Network
Research output
(68)
Activities
(55)
Press / Media
(19)
Teaching
(6)
Similar Profiles
(12)
Supervised Work
(2)
If you made any changes in Pure these will be visible here soon.
Fingerprint
Fingerprints are formed from scientific publications and create an index of weighted keyword concepts for each individual researcher.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Schwann Cells
100%
Induced Pluripotent Stem Cells
90%
Neuroglia
73%
Neurons
64%
Central Nervous System
52%
Insulin-Like Growth Factor II
50%
Brain
49%
Multiple Sclerosis
48%
Sciatic Nerve
47%
Autism Spectrum Disorder
46%
Oligodendroglia
44%
Cell Line
44%
Astrocytes
40%
Halogenated Diphenyl Ethers
40%
Insulin-Like Growth Factor I
40%
Proteins
40%
Ranvier's Nodes
39%
Fibroblasts
38%
Stem Cells
37%
Germ Layers
36%
Axons
35%
Demyelinating Diseases
35%
Microglia
34%
Peripheral Nervous System
33%
In Vitro Techniques
32%
Differentiation Antigens
32%
Nerve Regeneration
32%
Thymidine
30%
Spinal Cord
29%
Proteome
29%
Cell Proliferation
29%
Coculture Techniques
29%
Communication
28%
Chromosome Aberrations
28%
Cerebrospinal Fluid
27%
Enteric Nervous System
27%
High-Temperature Requirement A Serine Peptidase 1
27%
Cadherins
27%
Mouse Mirn146 microRNA
26%
Rhodothermus
26%
Cerebral Cortex
26%
Remyelination
26%
Oligodendrocyte-Myelin Glycoprotein
24%
Wounds and Injuries
24%
Insulin
24%
Regeneration
24%
Plasmids
23%
3-Hydroxysteroid Dehydrogenases
23%
Bromodeoxyuridine
22%
Chronic Progressive Multiple Sclerosis
22%